BCA
ANGO icon

Berman Capital Advisors’s AngioDynamics ANGO Stock Holding History

Berman Capital Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1K Buy
+72
New +$1.93K ﹤0.01% 1796

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berman Capital Advisors's ANGO Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in AngioDynamics (ANGO) in Q3 2021: 72 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1796 among its holdings.

156 funds tracked by Wall St. Rank hold ANGO as of Q3 2021.

  • Berman Capital Advisors held 72 shares of AngioDynamics worth $1K as of Q3 2021.
  • AngioDynamics was a new Berman Capital Advisors position in Q3 2021.
  • AngioDynamics made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1796 holding.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.